BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27519163)

  • 1. Quantitative proteome analysis reveals the correlation between endocytosis-associated proteins and hepatocellular carcinoma dedifferentiation.
    Naboulsi W; Bracht T; Megger DA; Reis H; Ahrens M; Turewicz M; Eisenacher M; Tautges S; Canbay AE; Meyer HE; Weber F; Baba HA; Sitek B
    Biochim Biophys Acta; 2016 Nov; 1864(11):1579-85. PubMed ID: 27519163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
    Huang GH; Shan H; Li D; Zhou B; Pang PF
    Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
    Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
    J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer.
    Caballero-Díaz D; Bertran E; Peñuelas-Haro I; Moreno-Càceres J; Malfettone A; López-Luque J; Addante A; Herrera B; Sánchez A; Alay A; Solé X; Serrano T; Ramos E; Fabregat I
    J Hepatol; 2020 Jan; 72(1):125-134. PubMed ID: 31562907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
    Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T
    Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma.
    Yamamoto Y; Sakamoto M; Fujii G; Kanetaka K; Asaka M; Hirohashi S
    Clin Cancer Res; 2001 Feb; 7(2):297-303. PubMed ID: 11234883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.
    Qi Y; Xu F; Chen L; Li Y; Xu Z; Zhang Y; Wei W; Su N; Zhang T; Fan F; Wang X; Qin X; Zhang L; Liu Y; Xu P
    Oncotarget; 2016 Oct; 7(42):68242-68252. PubMed ID: 27626164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional analysis of differentially expressed genes in poorly differentiated hepatocellular carcinoma using RNA-seq.
    Huang Y; Pan J; Chen D; Zheng J; Qiu F; Li F; Wu Y; Wu W; Huang X; Qian J
    Oncotarget; 2017 May; 8(22):35973-35983. PubMed ID: 28415592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M
    Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.
    Liu F; Zhu C; Huang X; Cai J; Wang H; Wang X; He S; Liu C; Yang X; Zhang Y; Zhang T
    Pathol Res Pract; 2014 Dec; 210(12):885-92. PubMed ID: 25169131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
    Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH
    Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of tetraspanin CO-029 in hepatocellular carcinoma.
    Kanetaka K; Sakamoto M; Yamamoto Y; Yamasaki S; Lanza F; Kanematsu T; Hirohashi S
    J Hepatol; 2001 Nov; 35(5):637-42. PubMed ID: 11690710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of fibroblast growth factor receptor 2 expression in differentiation of hepatocellular carcinoma.
    Harimoto N; Taguchi K; Shirabe K; Adachi E; Sakaguchi Y; Toh Y; Okamura T; Kayashima H; Taketomi A; Maehara Y
    Oncology; 2010; 78(5-6):361-8. PubMed ID: 20798558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
    Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
    Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
    Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
    Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma.
    Akiba J; Ogasawara S; Kawahara A; Nishida N; Sanada S; Moriya F; Kuwano M; Nakashima O; Yano H
    Oncol Rep; 2008 Dec; 20(6):1329-35. PubMed ID: 19020710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells.
    Trerè D; Fiume L; De Giorgi LB; Di Stefano G; Migaldi M; Derenzini M
    Br J Cancer; 1999 Oct; 81(3):404-8. PubMed ID: 10507763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma.
    Zhang D; Lim SG; Koay ES
    Int J Oncol; 2007 Sep; 31(3):577-84. PubMed ID: 17671684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia upregulates Rab11-family interacting protein 4 through HIF-1α to promote the metastasis of hepatocellular carcinoma.
    Hu F; Deng X; Yang X; Jin H; Gu D; Lv X; Wang C; Zhang Y; Huo X; Shen Q; Luo Q; Zhao F; Ge T; Zhao F; Chu W; Shu H; Yao M; Fan J; Qin W
    Oncogene; 2015 Dec; 34(49):6007-17. PubMed ID: 25745995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissues.
    Sakemi R; Yano H; Ogasawara S; Akiba J; Nakashima O; Fukahori S; Sata M; Kojiro M
    Oncol Rep; 2007 Jul; 18(1):65-70. PubMed ID: 17549347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.